Ningbo Menovo Pharmaceutical Co., Ltd. (SHA:603538)
23.27
+0.69 (3.06%)
Mar 10, 2026, 3:00 PM CST
SHA:603538 Ratios and Metrics
Market cap in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | Current | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 - 2015 |
|---|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 9, 2026 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2019 - 2015 |
| Market Capitalization | 5,130 | 2,780 | 4,080 | 5,494 | 5,312 | 5,555 | Upgrade
|
| Market Cap Growth | 77.77% | -31.86% | -25.74% | 3.44% | -4.38% | 50.31% | Upgrade
|
| Enterprise Value | 5,829 | 3,503 | 4,620 | 6,181 | 5,934 | 5,985 | Upgrade
|
| Last Close Price | 23.27 | 12.68 | 19.04 | 25.44 | 24.99 | 26.13 | Upgrade
|
| PE Ratio | 51.38 | 41.62 | 352.19 | 16.22 | 37.27 | 35.62 | Upgrade
|
| Forward PE | - | 13.31 | 23.46 | 18.90 | 24.70 | 23.60 | Upgrade
|
| PS Ratio | 3.33 | 2.03 | 3.35 | 3.77 | 4.22 | 4.66 | Upgrade
|
| PB Ratio | 2.12 | 1.21 | 1.87 | 2.53 | 2.69 | 3.13 | Upgrade
|
| P/TBV Ratio | 2.43 | 1.40 | 2.11 | 2.83 | 3.43 | 4.14 | Upgrade
|
| P/OCF Ratio | 89.27 | 28.51 | 446.76 | 19.84 | 24.08 | 24.36 | Upgrade
|
| EV/Sales Ratio | 3.78 | 2.55 | 3.80 | 4.24 | 4.72 | 5.02 | Upgrade
|
| EV/EBITDA Ratio | 20.17 | 15.68 | 33.01 | 20.35 | 22.07 | 24.91 | Upgrade
|
| EV/EBIT Ratio | 40.48 | 37.33 | 175.24 | 30.09 | 34.92 | 39.18 | Upgrade
|
| Debt / Equity Ratio | 0.53 | 0.59 | 0.60 | 0.55 | 0.64 | 0.45 | Upgrade
|
| Debt / EBITDA Ratio | 4.47 | 5.91 | 8.99 | 3.92 | 4.69 | 3.33 | Upgrade
|
| Net Debt / Equity Ratio | 0.25 | 0.26 | 0.26 | 0.09 | 0.24 | 0.21 | Upgrade
|
| Net Debt / EBITDA Ratio | 2.08 | 2.69 | 4.13 | 0.64 | 1.74 | 1.58 | Upgrade
|
| Net Debt / FCF Ratio | -8.11 | -7.35 | -2.75 | -0.66 | -1.51 | -4.31 | Upgrade
|
| Asset Turnover | 0.33 | 0.30 | 0.28 | 0.35 | 0.35 | 0.42 | Upgrade
|
| Inventory Turnover | 1.23 | 1.37 | 1.45 | 1.52 | 1.53 | 1.85 | Upgrade
|
| Quick Ratio | 0.65 | 0.71 | 0.80 | 0.90 | 0.90 | 0.56 | Upgrade
|
| Current Ratio | 1.28 | 1.24 | 1.28 | 1.39 | 1.48 | 1.03 | Upgrade
|
| Return on Equity (ROE) | 4.67% | 3.40% | 0.74% | 17.71% | 8.42% | 9.67% | Upgrade
|
| Return on Assets (ROA) | 1.92% | 1.29% | 0.37% | 3.05% | 2.98% | 3.33% | Upgrade
|
| Return on Invested Capital (ROIC) | 4.33% | 2.90% | 1.03% | 8.17% | 6.48% | 6.26% | Upgrade
|
| Return on Capital Employed (ROCE) | 4.60% | 3.10% | 0.90% | 6.70% | 6.00% | 7.80% | Upgrade
|
| Earnings Yield | 1.94% | 2.40% | 0.28% | 6.17% | 2.68% | 2.81% | Upgrade
|
| FCF Yield | -1.43% | -2.94% | -5.16% | -5.36% | -5.82% | -1.59% | Upgrade
|
| Dividend Yield | 0.22% | 0.39% | 0.10% | 0.65% | 0.57% | - | Upgrade
|
| Payout Ratio | 36.88% | 34.00% | 511.34% | 14.76% | 9.71% | 26.61% | Upgrade
|
| Buyback Yield / Dilution | 7.69% | 6.99% | -1.89% | -6.91% | -3.50% | -0.07% | Upgrade
|
| Total Shareholder Return | 7.91% | 7.39% | -1.78% | -6.26% | -2.93% | -0.07% | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.